82 FR 23067 - Bulk Manufacturer of Controlled Substances Application: Eli-Elsohly Laboratories
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 82, Issue 96 (May 19, 2017)
Drug Enforcement Administration
Federal Register Volume 82, Issue 96 (May 19, 2017)
| Page Range | 23067-23068 | |
| FR Document | 2017-10241 |
[Federal Register Volume 82, Number 96 (Friday, May 19, 2017)] [Notices] [Pages 23067-23068] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-10241] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Bulk Manufacturer of Controlled Substances Application: Eli- Elsohly Laboratories ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic class, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before July 18, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on March 3, 2017, Eli-Elsohly Laboratories, Mahmoud A. Elsohly Ph. D., 5 Industrial Park Drive, Oxford, Mississippi 38655 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Drug code Schedule ------------------------------------------------------------------------ Marihuana Extract.................. 7350 I Marihuana.......................... 7360 I Tetrahydrocannabinols.............. 7370 I Dihydromorphine.................... 9145 I Amphetamine........................ 1100 II Methamphetamine.................... 1105 II Cocaine............................ 9041 II Codeine............................ 9050 II Dihydrocodeine..................... 9120 II Oxycodone.......................... 9143 II Hydromorphone...................... 9150 II Ecgonine........................... 9180 II Hydrocodone........................ 9193 II Morphine........................... 9300 II Thebaine........................... 9333 II ------------------------------------------------------------------------ [[Page 23068]] The company plans to manufacture the listed controlled substances for product development and reference standards. In reference to drug codes 7360 (marihuana) and 7370 (THC) the company plans to isolate these controlled substances from procured 7350 (marihuana extract). In reference to drug code 7360 no cultivation activities are authorized for this registration. No other activities for these drug codes are authorized for this registration. Dated: May 15, 2017. Louis J. Milione, Assistant Administrator. [FR Doc. 2017-10241 Filed 5-18-17; 8:45 am] BILLING CODE P
![Federal Register / Vol. 82, No. 96 / Friday, May 19, 2017 / Notices 23067
Administrator’’) pursuant to section 7 of Morrissette Drive, Springfield, Virginia DATES: Registered bulk manufacturers of
28 CFR part 0, appendix to subpart R. 22152. the affected basic class, and applicants
In accordance with 21 CFR SUPPLEMENTARY INFORMATION: The therefore, may file written comments on
1301.33(a), this is notice that on March Attorney General has delegated his or objections to the issuance of the
21, 2017, Insys Manufacturing, LLC, authority under the Controlled proposed registration in accordance
2700 Oakmont Drive, Round Rock, Substances Act to the Administrator of with 21 CFR 1301.33(a) on or before July
Texas 78665 applied to be registered as the Drug Enforcement Administration 18, 2017.
a bulk manufacturer of the following (DEA), 28 CFR 0.100(b). Authority to
basic classes of controlled substances: ADDRESSES: Written comments should
exercise all necessary functions with
respect to the promulgation and be sent to: Drug Enforcement
Controlled substance Schedule implementation of 21 CFR part 1301, Administration, Attention: DEA Federal
incident to the registration of Register Representative/DRW, 8701
Marihuana (7360) ......................... I Morrissette Drive, Springfield, Virginia
Tetrahydrocannabinols (7370) ..... I manufacturers, distributors, dispensers,
importers, and exporters of controlled 22152.
The company plans to manufacture substances (other than final orders in
SUPPLEMENTARY INFORMATION: The
bulk synthetic active pharmaceutical connection with suspension, denial, or
Attorney General has delegated his
ingredients (APIs) for product revocation of registration) has been
redelegated to the Assistant authority under the Controlled
development and distribution to its Substances Act to the Administrator of
customers. No other activity for these Administrator of the DEA Diversion
Control Division (‘‘Assistant the Drug Enforcement Administration
drug codes is authorized for this (DEA), 28 CFR 0.100(b). Authority to
registration. Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R. exercise all necessary functions with
Dated: May 15, 2017. In accordance with 21 CFR respect to the promulgation and
Louis J. Milione, 1301.33(a), this is notice that on implementation of 21 CFR part 1301,
Assistant Administrator. December 2, 2016, Patheon incident to the registration of
[FR Doc. 2017–10230 Filed 5–18–17; 8:45 am] Pharmaceuticals, Inc., 2110 E. Galbraith manufacturers, distributors, dispensers,
BILLING CODE 4410–09–P Road, Cincinnati, Ohio 45237 applied to importers, and exporters of controlled
be registered as a bulk manufacturer of substances (other than final orders in
gamma hydroxybutyric acid (2010) a connection with suspension, denial, or
DEPARTMENT OF JUSTICE basic class of controlled substance listed revocation of registration) has been
in schedule I. redelegated to the Assistant
Drug Enforcement Administration The company plans to manufacture Administrator of the DEA Diversion
the listed controlled substance for Control Division (‘‘Assistant
[Docket No. DEA–392] product development.
Administrator’’) pursuant to section 7 of
Dated: May 15, 2017. 28 CFR part 0, appendix to subpart R.
Bulk Manufacturer of Controlled
Substances Application: Patheon Louis J. Milione,
In accordance with 21 CFR
Pharmaceuticals, Inc. Assistant Administrator.
1301.33(a), this is notice that on March
[FR Doc. 2017–10238 Filed 5–18–17; 8:45 am]
3, 2017, Eli-Elsohly Laboratories,
ACTION: Notice of application. BILLING CODE 4410–09–P
Mahmoud A. Elsohly Ph. D., 5
DATES: Registered bulk manufacturers of Industrial Park Drive, Oxford,
the affected basic class, and applicants DEPARTMENT OF JUSTICE Mississippi 38655 applied to be
therefore, may file written comments on registered as a bulk manufacturer of the
or objections to the issuance of the Drug Enforcement Administration following basic classes of controlled
proposed registration in accordance substances:
[Docket No. DEA–392]
with 21 CFR 1301.33(a) on or before July
18, 2017. Bulk Manufacturer of Controlled
ADDRESSES: Written comments should Substances Application: Eli-Elsohly
be sent to: Drug Enforcement Laboratories
Administration, Attention: DEA Federal
ACTION: Notice of application.
Register Representative/DRW 8701
Controlled substance Drug code Schedule
Marihuana Extract ........................................................................................................................................................... 7350 I
Marihuana ........................................................................................................................................................................ 7360 I
Tetrahydrocannabinols .................................................................................................................................................... 7370 I
Dihydromorphine ............................................................................................................................................................. 9145 I
Amphetamine ................................................................................................................................................................... 1100 II
Methamphetamine ........................................................................................................................................................... 1105 II
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Cocaine ............................................................................................................................................................................ 9041 II
Codeine ........................................................................................................................................................................... 9050 II
Dihydrocodeine ................................................................................................................................................................ 9120 II
Oxycodone ....................................................................................................................................................................... 9143 II
Hydromorphone ............................................................................................................................................................... 9150 II
Ecgonine .......................................................................................................................................................................... 9180 II
Hydrocodone ................................................................................................................................................................... 9193 II
Morphine .......................................................................................................................................................................... 9300 II
Thebaine .......................................................................................................................................................................... 9333 II
VerDate Sep<11>2014 19:15 May 18, 2017 Jkt 241001 PO 00000 Frm 00115 Fmt 4703 Sfmt 4703 E:\FR\FM\19MYN1.SGM 19MYN1](https://thefederalregister.org/doc/82_FR_23163/page/1.svg)
![23068 Federal Register / Vol. 82, No. 96 / Friday, May 19, 2017 / Notices
The company plans to manufacture DEPARTMENT OF JUSTICE Substances Act to the Administrator of
the listed controlled substances for the Drug Enforcement Administration
product development and reference Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to
standards. In reference to drug codes [Docket No. DEA–392] exercise all necessary functions with
7360 (marihuana) and 7370 (THC) the respect to the promulgation and
company plans to isolate these Bulk Manufacturer of Controlled implementation of 21 CFR part 1301,
controlled substances from procured Substances Application: National incident to the registration of
7350 (marihuana extract). In reference to Center for Natural Products Research manufacturers, distributors, dispensers,
drug code 7360 no cultivation activities NIDA MPROJECT importers, and exporters of controlled
are authorized for this registration. No substances (other than final orders in
ACTION: Notice of application.
other activities for these drug codes are connection with suspension, denial, or
authorized for this registration. DATES: Registered bulk manufacturers of revocation of registration) has been
the affected basic class, and applicants redelegated to the Assistant
Dated: May 15, 2017.
therefore, may file written comments on Administrator of the DEA Diversion
Louis J. Milione,
or objections to the issuance of the Control Division (‘‘Assistant
Assistant Administrator. Administrator’’) pursuant to section 7 of
proposed registration in accordance
[FR Doc. 2017–10241 Filed 5–18–17; 8:45 am] with 21 CFR 1301.33(a) on or before July 28 CFR part 0, appendix to subpart R.
BILLING CODE P 18, 2017. In accordance with 21 CFR
ADDRESSES: Written comments should 1301.33(a), this is notice that on January
be sent to: Drug Enforcement 20, 2017, National Center for Natural
Administration, Attention: DEA Federal Products Research NIDA MPROJECT,
Register Representative/DRW, 8701 University of Mississippi, 135 Coy
Morrissette Drive, Springfield, Virginia Waller Complex, P.O. Box 1848,
22152. University, Mississippi 38677–1848
SUPPLEMENTARY INFORMATION: The applied to be registered as a bulk
Attorney General has delegated his manufacturer of the following basic
authority under the Controlled classes of controlled substances:
Controlled substance Drug code Schedule
Marihuana Extract ........................................................................................................................................................... 7350 I
Marihuana ........................................................................................................................................................................ 7360 I
Tetrahydrocannabinols .................................................................................................................................................... 7370 I
The company plans to bulk DEPARTMENT OF JUSTICE authority under the Controlled
manufacture the listed controlled Substances Act to the Administrator of
substances to make available to the Drug Enforcement Administration the Drug Enforcement Administration
National Institute on Drug Abuse [Docket No. DEA–392] (DEA), 28 CFR 0.100(b). Authority to
(NIDA) a supply of bulk marihuana for exercise all necessary functions with
distribution to research investigators in Bulk Manufacturer of Controlled respect to the promulgation and
support of the national research Substances Application: Chemtos, implementation of 21 CFR part 1301,
program needs. No other activities for LLC incident to the registration of
these drug codes are authorized for this manufacturers, distributors, dispensers,
ACTION: Notice of application.
registration. importers, and exporters of controlled
Dated: May 15, 2017. DATES: Registered bulk manufacturers of substances (other than final orders in
the affected basic class, and applicants connection with suspension, denial, or
Louis J. Milione,
therefore, may file written comments on revocation of registration) has been
Assistant Administrator. redelegated to the Assistant
or objections to the issuance of the
[FR Doc. 2017–10239 Filed 5–18–17; 8:45 am] Administrator of the DEA Diversion
proposed registration in accordance
BILLING CODE P with 21 CFR 1301.33(a) on or before July Control Division (‘‘Assistant
18, 2017. Administrator’’) pursuant to section 7 of
ADDRESSES: Written comments should 28 CFR part 0, appendix to subpart R.
be sent to: Drug Enforcement In accordance with 21 CFR
Administration, Attention: DEA Federal 1301.33(a), this is notice that on July 5,
Register Representative/DRW, 8701 2016, Chemtos, LLC, 14101 W. Highway
Morrissette Drive, Springfield, Virginia 290, Building 2000B, Austin, Texas
22152. 78737–9331 applied to be registered as
asabaliauskas on DSK3SPTVN1PROD with NOTICES
SUPPLEMENTARY INFORMATION: The a bulk manufacturer for the following
Attorney General has delegated his basic classes of controlled substances:
Controlled substance Drug code Schedule
Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... 1248 I
Methaqualone .................................................................................................................................................................. 2565 I
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ................................................................................................... 6250 I
5-Flouro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ................. 7011 I
VerDate Sep<11>2014 19:15 May 18, 2017 Jkt 241001 PO 00000 Frm 00116 Fmt 4703 Sfmt 4703 E:\FR\FM\19MYN1.SGM 19MYN1](https://thefederalregister.org/doc/82_FR_23163/page/2.svg)
Document Created: 2018-11-08 08:48:14
Document Modified: 2018-11-08 08:48:14
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic class, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before July 18, 2017. | |
| FR Citation | 82 FR 23067 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR